Can herbs provide a new generation of drugs for treating Alzheimer's disease?

Brain Research Reviews

Volumn 50, Issue 2, 2005, Pages 361-376

  Anekonda, Thimmappa S ^a   Reddy, P Hemachandra ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Animal model; Bioavailability; Herbal drug; In vitro model; Mitochondria

Indexed keywords

ALKALOID; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBYL PALMITATE; BETA ASARONE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CURCUMIN; DONEPEZIL; EUGENOL; FLAVONOID; GALANTAMINE; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HUPERZINE A; INDIRUBIN; MELATONIN; MEMANTINE; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE DERIVATIVE; PLANT EXTRACT; POLYPHENOL DERIVATIVE; PYCNOGENOL; TACRINE; TERPENE DERIVATIVE; THIOCTIC ACID; UNINDEXED DRUG;

ABDOMINAL PAIN; ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; ANIMAL MODEL; ASEPTIC MENINGOENCEPHALITIS; AUTOPSY; BLOOD BRAIN BARRIER; CELL ACTIVITY; CHEMICAL COMPOSITION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CYTOLOGY; DISEASE COURSE; DIZZINESS; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG SCREENING; ENZYME INHIBITION; GASTROINTESTINAL DISEASE; HEADACHE; HERBAL MEDICINE; HUMAN; IN VITRO STUDY; MENINGOENCEPHALITIS; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NAUSEA; NERVOUSNESS; NEUROFIBRILLARY TANGLE; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SKIN ALLERGY; SYNAPSE; TOXICITY; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING; WHEEZING;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; HUMANS; MEDICINE, HERBAL; PLANT EXTRACTS;

EID: 27844592673     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2005.09.001     Document Type: Review

References (168)

1. N. Abbas, I. Bednar, E. Mix, S. Marie, D. Paterson, A. Ljungberg, C. Morris, B. Winblad, A. Nordberg, and J. Zhu Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice J. Neuroimmunol. 126 2002 50 57
2. F.I. Achike, and C.Y. Kwan Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway Clin. Exp. Pharmacol. Physiol. 30 2003 605 615
3. B. Ahlemeyer, and J. Krieglstein Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease Pharmacopsychiatry 36 Suppl. 1 2003 S8 S14
4. S. Akhondzadeh, M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi, and M. Khani Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial J. Neurol., Neurosurg. Psychiatry 74 2003 863 866
5. S. Akhondzadeh, M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi, and M. Khani Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial J. Clin. Pharm. Ther. 28 2003 53 59
6. H. Allain, D. Bentue-Ferrer, O. Tribut, S. Gauthier, B.F. Michel, and C. Drieu-La Rochelle Alzheimer's disease: the pharmacological pathway Fundam. Clin. Pharmacol. 17 2003 419 428
7. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin, and N.G. Avadhani Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells J. Cell Biol. 161 2003 41 54
8. S. Andrieu, S. Gillette, K. Amouyal, F. Nourhashemi, E. Reynish, P.J. Ousset, J.L. Albarede, B. Vellas, and H. Grandjean EPIDOS study. Association of Alzheimer's disease onset with Ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 58 2003 372 377
9. M.K. Ang-Lee, J. Moss, and C.S. Yuan Herbal medicines and perioperative care JAMA 286 2001 208 216
10. C.G. Ballard, J.T. O'Brien, K. Reichelt, and E.K. Perry Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa J. Clin. Psychiatry 63 2002 553 558
11. S. Bastianetto, and R. Quirion EGb 761 is a neuroprotective agent against beta-amyloid toxicity Cell. Mol. Biol. (Noisy-le-Grand) 48 2002 693 697
12. S. Bastianetto, W.H. Zheng, and R. Quirion The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C J. Neurochem. 74 2000 2268 2277
13. S. Bastianetto, C. Ramassamy, S. Dore, Y. Christen, J. Poirier, and R. Quirion The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid Eur. J. Neurosci. 12 2000 1882 1890
14. C. Bate, M. Salmona, and A. Williams Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42 J. Neuroinflammation 1 2004 4
15. C. Bertoni-Freddari, P. Fattoretti, U. Caselli, R. Paoloni, and M. Solazzi Chronic administration of EGb 761 modulates synaptic and mitochondrial plasticity in adult vitamin E-deficient rats Cell. Mol. Biol. (Noisy-le-Grand) 48 2002 709 715
16. S.K. Bhattacharya, A. Bhattacharya, A. Kumar, and S. Ghosal Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus Phytother. Res. 14 2000 174 179
17. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol. Med. 7 2001 548 554
18. E.A. Carlini Plants and the central nervous system Pharmacol. Biochem. Behav. 75 2003 501 512
19. S.S. Chatterjee, E.L. Kondratskaya, and O.A. Krishtal Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators Pharmacopsychiatry 36 Suppl. 1 2003 S68 S77
20. X.C. Chen, L.M. Chen, Y.G. Zhu, F. Fang, Y.C. Zhou, and C.H. Zhao Involvement of CDK4, pRB, and E2F1 in ginsenoside Rg1 protecting rat cortical neurons from beta-amyloid-induced apoptosis Acta Pharmacol. Sin. 24 2003 1259 1264
21. Y.T. Choi, C.H. Jung, S.R. Lee, J.H. Bae, W.K. Baek, M.H. Suh, J. Park, C.W. Park, and S.I. Suh The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons Life Sci. 70 2001 603 614
22. B.A. Chromy, R.J. Nowak, M.P. Lambert, K.L. Viola, L. Chang, P.T. Velasco, B.W. Jones, S.J. Fernandez, P.N. Lacor, P. Horowitz, C.E. Finch, G.A. Krafft, and W.L. Klein Self-assembly of Abeta(1-42) into globular neurotoxins Biochemistry 42 2003 12749 12760
23. F. Colciaghi, B. Borroni, M. Zimmermann, C. Bellone, A. Longhi, A. Padovani, F. Cattabeni, Y. Christen, and M. Di Luca Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts Neurobiol. Dis. 16 2004 454 460
24. P.E. Coskun, M.F. Beal, and D.C. Wallace Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication Proc. Natl. Acad. Sci. U. S. A. 101 2004 10726 10731
25. S.E. Counts, M. Nadeem, J. Wuu, S.D. Ginsberg, H.U. Saragovi, and E.J. Mufson Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease Ann. Neurol. 56 2004 520 531
26. S.M. de la Monte, and J.R. Wands Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease J. Alzheimer's Dis. 7 2005 45 61
27. R.B. DeMattos, K.R. Bales, D.J. Cummins, J.C. Dodart, S.M. Paul, and D.M. Holtzman Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 98 2001 8850 8855
28. R.B. DeMattos, K.R. Bales, D.J. Cummins, J.C. Paul, and D.M. Holtzman Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science 295 2002 2264 2267
29. A.M. Duncan, W.R. Phipps, and M.S. Kurzer Phyto-oestrogens Best Pract. Res., Clin. Endocrinol. Metabol. 17 2003 253 271
30. A. Eckert, U. Keil, S. Kressmann, K. Schindowski, S. Leutner, S. Leutz, and W.E. Muller Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress Pharmacopsychiatry 36 Suppl. 1 2003 S15 S23
31. Z. Feng, Y. Chang, Y. Cheng, B.L. Zhang, Z.W. Qu, C. Qin, and J.T. Zhang Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease J. Pineal Res. 37 2004 129 136
32. L. Gasparini, E. Ongini, and G. Wenk Nonsteroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action J. Neurochemistry 91 2004 521 536
33. L. Gasparini, E. Ongini, D. Wicock, and D. Morgan Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease Brain Res. Rev. 48 2005 400 408
34. D.S. Gelinas, K. DaSilva, D. Fenili, P. St George-Hyslop, and J. McLaurin Immunotherapy for Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 101 Suppl. 2 2004 14657 14662
35. P.K. Giri, V. Rajagopal, and V.K. Kalra Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor J. Neurochem. 91 2004 1199 1210
36. V. Glaser Billion-dollar market blossoms as botanicals take root Nat. Biotechnol. 17 1999 17 18
37. R.K. Gordon, S.V. Nigam, J.A. Weitz, J.R. Dave, B.P. Doctor, and H.S. Ved The NMDA receptor ion channel: a site for binding of Huperzine A J. Appl. Toxicol. 21 Suppl. 1 2001 S47 S51
38. S.G. Gray, and A.A. Clair Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges Am. J. Alzheimer's Dis. Other Dement. 17 2002 169 174
39. M. Grundman, M. Grundman, and P. Delaney Antioxidant strategies for Alzheimer's disease Proc. Nutr. Soc. 61 2002 191 202
40. M. Hashimoto, H. Kazui, K. Matsumoto, Y. Nakano, M. Yasuda, and E. Mori Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am. J. Psychiatry 162 2005 676 682
41. E. Hellstrom-Lindahl, J. Court, J. Keverne, M. Svedberg, M. lee, A. Marutle, A. Thomas, E. Perry, I. Bednar, and A. Nordberg Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice Eur. J. Neurosci. 19 2004 2703 2710
42. H.J. Heo, S.C. Hong, H.Y. Cho, B. Hong, H.K. Kim, E.K. Kim, and D.H. Shin Inhibitory effect of zeatin, isolated from Fiatoua villosa, on acetylcholinesterase activity from PC12 cells Mol. Cells 13 2002 113 117
43. C. Holmes Genotype and phenotypes in Alzheimer's disease Br. J. Psychiatry 180 2002 131 134
44. C. Holmes, V. Hopkins, C. Hensford, V. MacLaughlin, D. Wilkinson, and H. Rosenvinge Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study Int. J. Geriatr. Psychiatry 17 2002 305 308
45. P.J. Houghton Plants and central nervous system Pharmacol. Biochem. Behav. 75 2003 497 499 (Editorial)
46. M.J. Howes, and P.J. Houghton Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function Pharmacol. Biochem. Behav. 75 2003 513 527
47. M.J. Howes, N.S. Perry, and P.J. Houghton Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders Phytother. Res. 17 2003 1 18
48. K.C. Huang The Pharmacology of Chinese Herbs 1999 CRC Press Boca Raton, FL, USA 344
49. Y. Irie, and W.M. Keung Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-beta peptide Brain Res. 963 2003 282 289
50. J.H. Jang, and Y.J. Surh Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death Free Radical Biol. Med. 34 2003 1100 1110
51. H. Jia, Y. Jiang, Y. Ruan, Y. Zhang, X. Ma, J. Zhang, K. Beyreuther, P. Tu, and D. Zhang Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid beta-protein in cultured cells Neurosci. Lett. 367 2004 123 128
52. R.R. Jonnala, A.V. Terry Jr., and J.J. Buccafusco Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo Life Sci. 70 2002 1543 1554
53. S.Y. Kang, K.Y. Lee, K.A. Koo, J.S. Yoon, S.W. Lim, Y.C. Kim, and S.H. Sung ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice Life Sci. 76 2005 1691 1705
54. S. Kanowski, and R. Hoerr Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial Pharmacopsychiatry 36 2003 297 303
55. H.K. Kim, M. Kim, S. Kim, M. Kim, and J.H. Chung Effects of green tea polyphenol on cognitive and acetylcholinesterase activities Biosci. Biotechnol. Biochem. 68 2004 1977 1979
56. M. Kitazawa, T. Yamasaki, and F.M. LaFerla Microglia as a potential bridge between the amyloid β-peptide and Tay Ann. N. Y. Acad. Sci. 1035 2004 85 103
57. R.P. Koldamova, I.M. Lefterov, M. Staufenbiel, D. Wolfe, S. Huang, J.C. Glorioso, M. Walter, M.G. Roth, and J.S. Lazo The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease J. Biol. Chem. 280 2005 4079 4088
58. A.N. Kong, R. Yu, C. Chen, S. Mandlekar, and T. Primiano Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis Arch. Pharm. Res. 23 2000 1 16
59. B.S. Koo, Y.K. Kim, K.S. Park, K.H. Chung, and C.H. Kim Attenuating effect of a traditional korean formulation, Paeng-Jo-Yeon-Nyeon-Baek-Ja-In-Hwan (PJBH), on hydrogen peroxide-induced injury in PC12 cells Phytother. Res. 18 2004 488 493
60. B.S. Koo, W.C. Lee, K.H. Chung, J.H. Ko, and C.H. Kim A water extract of Curcuma longa L. (Zingiberaceae) rescues PC12 cell death caused by pyrogallol or hypoxia/reoxygenation and attenuates hydrogen peroxide induced injury in PC12 cells Life Sci. 75 2004 2363 2375
61. N.F. Krebs Bioavailability of dietary supplements and impact of physiologic state: infants, children and adolescents J. Nutr. 31 Suppl. 4 2001 Apr. 1351S 1354S
62. L.J. Launer Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next? JAMA 289 2003 287 2865 (Erratum in: JAMA. 290 (2003) 1154)
63. P.L. Le Bars Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles Pharmacopsychiatry 36 Suppl. 1 2003 S50 S55
64. S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J.A. Bibb, G.L. Snyder, P. Greengard, J. Biernat, Y.Z. Wu, E.M. Mandelkow, G. Eisenbrand, and L. Meijer Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors J. Biol. Chem. 276 2001 251 260
65. M.D. Li, J.K. Kane, S.G. Matta, W.S. Blaner, and B.M. Sharp Nicotine enhances the biosynthesis and secretion of transthyretin from the choroid plexus in rats: implications for beta-amyloid formation J. Neurosci. 20 2000 1318 1323
66. F. Li, N.Y. Calingasan, F. Yu, W.M. Mauck, M. Toidze, C.G. Almeida, R.H. Takahashi, G.A. Carlson, M.F. Beal, M.T. Lin, and G.K. Gouras Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice J. Neurochem. 89 2004 1308 1312
67. Y.Q. Liang, and X.C. Tang Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats Neurosci. Lett. 361 2004 56 59
68. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, and G.M. Cole The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J. Neurosci. 21 2001 8370 8377
69. C.P. Liu, W.J. Tsai, Y.L. Lin, J.F. Liao, C.F. Chen, and Y.C. Kuo The extracts from Nelumbo nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells Life Sci. 75 2004 699 716
70. J.X. Liu, W.H. Cong, L. Xu, and J.N. Wang Effect of combination of extracts of ginseng and Ginkgo biloba on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC Acta Pharmacol. Sin. 25 2004 1118 1123
71. S. Lopez, J. Bastida, F. Viladomat, and C. Codina Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts Life Sci. 71 2002 2521 2529
72. M.A. Lovell, W.D. Ehmann, S.M. Butler, and W.R. Markesbery Elevated thiobarbituric acid-eactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease Neurology 45 1995 1594 1601
73. Y. Luo, J.V. Smith, V. Paramasivam, A. Burdick, K.J. Curry, J.P. Buford, I. Khan, W.J. Netzer, H. Xu, and P. Butko Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 Proc. Natl. Acad. Sci. U. S. A. 99 2002 12197 12202
74. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
75. L. Lyras, R.H. Perry, E.K. Perry, P.G. Ince, P. Jenner, and B. Halliwell Oxidative damage to proteins, lipids, and antioxidant enzyme regions from patients with dementia with Lewy bodies J. Neurochem. 71 1998 302 312
76. J.J. Macheix, A. Fleuriet, and J. Billot Fruit Phenolics 1990 CRC Press, Inc. Boca Raton, FL, USA
77. K.M. Maclennan, C.L. Darlington, and P.F. Smith The CNS effects of Ginkgo biloba extracts and ginkgolide B Prog. Neurobiol. 67 2002 235 257
78. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans: I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 81 Suppl. 1 2005 230S 242S
79. M. Manczak, B.S. Park, Y. Jung, and P.H. Reddy Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage Neuromol. Med. 5 2004 147 162
80. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radical Biol. Med. 23 1998 134 147
81. W.R. Markesbery, and J.M. Carney Oxidative alterations in Alzheimer's disease Brain Pathol. 9 1999 133 146
82. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
83. J.B. McGraw, and M.A. Furedi Deer browsing and population viability of a forest understory plant Science 307 2005 920 922
84. L. Meda, M.A. Cassatella, G.I. Szendrei, L. Otvos Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rossi Activation of microglial cells by beta-amyloid protein and interferon-gamma Nature 374 1995 647 650
85. A. Merched, J.M. Serot, S. Visvikis, D. Aguillon, G. Faure, and G. Siest Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry FEBS Lett. 425 1998 225 228
86. A. Monsonego, and H.L. Weiner Immunotherapeutic approaches to Alzheimer's disease Science 302 2003 834 838
87. V. Morelli, and C. Naquin Alternative therapies for traditional disease states: menopause Am. Fam. Phys. 66 2002 129 134
88. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, J. Hardy, K. Duff, P. Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon, and G.W. Arendash A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
89. M.C. Morris, L.A. Beckett, P.A. Scherr, L.E. Hebert, D.A. Bennett, T.S. Field, and D.A. Evans Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease Alzheimer Dis. Assoc. Disord. 12 1998 121 126
90. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, R.S. Wilson, and P.A. Scherr Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study JAMA 287 2002 3230 3237
91. O. Nakagawasai, F. Yamadera, K. Iwasaki, H. Arai, R. Taniguchi, K. Tan-No, H. Sasaki, and T. Tadano Effect of kami-untan-to on the impairment of learning and memory induced by thiamine-deficient feeding in mice Neuroscience 125 2004 233 241
92. R.J. Nijveldt, E. van Nood, D.E. van Hoorn, P.G. Boelens, K. van Norren, and P.A. van Leeuwen Flavonoids: a review of probable mechanisms of action and potential applications Am. J. Clin. Nutr. 74 2001 418 425
93. A. Nordberg, E. Hellstrom-Lindahl, M. Lee, M. Johnson, M. Mousavi, R. Hall, E. Perry, L. Bednar, and J. Court Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 2002 655 658
94. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction Neuron 39 2003 409 421
95. S. Oddo, L. Billings, J.P. Kesslak, D.H. Cribbs, and F.M. LaFerla Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome Neuron 43 2004 321 332
96. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J. Neurosci. Res. 75 2004 742 750
97. E. Ognibene, S. Middei, S. Daniele, W. Adriani, O. Ghirardi, A. Caprioli, and G. Laviola Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease Behav. Brain Res. 156 2005 225 232
98. S.Y. Park, and D.S. Kim Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease J. Nat. Prod. 65 2002 1227 1231
99. Q. Peng, A.R. Buz'Zard, and B.H. Lau Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro Med. Sci. Monit. 8 2002 BR328 BR337
100. A.P. Periclou, D. Ventura, T. Sherman, N. Rao, and W.T. Abramowitz Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil Ann. Pharmacother. 38 2004 1389 1394
101. E.K. Perry, A.T. Pickering, W.W. Wang, P.J. Houghton, and N.S. Perry Medicinal plants and Alzheimer's disease: integrating ethnobotanical and contemporary scientific evidence J. Altern. Complement. Med. 4 1998 419 428
102. E.K. Perry, A.T. Pickering, W.W. Wang, P.J. Houghton, and N.S. Perry Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy J. Pharm. Pharmacol. 51 1999 527 534
103. N.S. Perry, P.J. Houghton, J. Sampson, A.E. Theobald, S. Hart, M. Lis-Balchin, J.R. Hoult, P. Evans, P. Jenner, S. Milligan, and E.K. Perry In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease J. Pharm. Pharmacol. 53 2001 1347 1356
104. N.S. Perry, P.J. Houghton, P. Jenner, A. Keith, and E.K. Perry Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo Phytomedicine 9 2002 48 51
105. N.S. Perry, C. Bollen, E.K. Perry, and C. Ballard Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial Pharmacol. Biochem. Behav. 75 2003 651 659
106. L. Qin, Y. Liu, C. Cooper, B. Liu, B. Wilson, and J.S. Hong Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species J. Neurochem. 83 2002 973 983
107. W.Q. Qiu, F.M. Folstein, Insulin, insulin-degrading enzyme and amyloid-b peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging (in press).
108. J. Raber Androgens, apoE, and Alzheimer's disease Sci. Aging Knowledge Environ. 2004 2004 re2
109. J. Raber, Y. Huang, and J.W. Ashford ApoE genotype accounts for the vast majority of AD risk and AD pathology Neurobiol. Aging 25 2004 641 650
110. C. Ramassamy, D. Averill, U. Beffert, S. Bastianetto, L. Theroux, S. Lussier-Cacan, J.S. Cohn, Y. Christen, J. Davignon, R. Quirion, and J. Poirier Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype Free Radical Biol. Med. 27 1999 544 553
111. I. Raskin, D.M. Ribnicky, S. Komarnytsky, N. Llic, A. Poulev, N. Borisjuk, A. Brinker, D.A. Moreno, C. Ripoll, N. Yakoby, J.M. O'Neil, T. Cornwell, I. Pastor, and B. Fridlender Plants and human health in the twenty-first century Trends Biotech. 20 2002 522 531
112. P.H. Reddy, M.F. Beal, Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res. Rev. (in press).
113. P.H. Reddy, and S. McWeeney Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant mouse models Neurobiol. Aging. 2005 (electronic publication ahead of print)
114. P.H. Reddy, S. McWeeney, B.S. Park, M. Manczak, R.V. Gutala, D. Partovi, Y. Jung, V. Yau, R. Searles, M. Mori, and J. Quinn Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease Hum. Mol. Genet. 13 2004 1225 1240
115. P.H. Reddy, G. Mani, B.S. Park, J. Jaques, G. Murdoch, W. Whetsell Jr., J. Kaye, and M. Manczak Differential loss of synaptic proteins in Alzheimer's Disease patients: implications to synaptic damage J. Alzheimer's Dis. 7 2005 103 117
116. Y. Ren, P.J. Houghton, R.C. Hider, and M.J. Howes Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza Planta Med. 70 2004 201 204
117. S. Rho, M. Kang, B. Choi, D. Sim, J. Lee, E. Lee, C. Cho, J.W. Oh, S. Park, S. Ko, M. Shin, M. Hong, and H. Bae Effects of Yukmijihwang-tang derivatives (YMJd), a memory enhancing herbal extract, on the gene-expression profile in the rat hippocampus Biol. Pharm. Bull. 28 2005 87 93
118. G. Rimbach, S. Wolffram, C. Watanabe, L. Packer, and K. Gohil Effect of Ginkgo biloba (EGb 761) on differential gene expression Pharmacopsychiatry 36 Suppl. 1 2003 S95 S99
119. R.K. Rishi Phytoestrogens in health and illness Indian J. Pharmacol. 34 2002 311 320
120. A. Russo, M. Palumbo, C. Aliano, L. Lempereur, G. Scoto, and M. Renis Red wine micronutrients as protective agents in Alzheimer-like induced insult Life Sci. 72 2003 2369 2379
121. A. Russo, F. Borrelli, A. Campisi, R. Acquaviva, G. Raciti, and A. Vanella Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera Life Sci. 73 2003 1517 1526
122. S.U. Savelev, E.J. Okello, and E.K. Perry Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents Phytother. Res. 18 2004 315 324
123. D. Schenk Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Nat. Rev., Neurosci. 3 2002 824 828
124. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
125. V. Schulz Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider Phytomedicine 10 Suppl. 4 2003 74 79
126. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
127. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
128. M. Sharma, and Y.K. Gupta Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats Life Sci. 71 2002 2489 2498
129. I.R. Siqueira, C. Fochesatto, A.L. da Silva, D.S. Nunes, A.M. Battastini, C.A. Netto, and E. Elisabetsky Ptychopetalum olacoides, a traditional Amazonian "nerve tonic", possesses anticholinesterase activity Pharmacol. Biochem. Behav. 75 2003 645 650
130. J. Smallwood, R. Brown, F. Coulter, F. Irvine, and C. Copland Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial Int. J. Geriatr. Psychiatry 16 2001 1010 1013
131. J.V. Smith, and Y. Luo Studies on molecular mechanisms of Ginkgo biloba extract Appl. Microbiol. Biotechnol. 64 2004 465 472
132. J.V. Smith, A.J. Burdick, P. Golik, I. Khan, D. Wallace, and Y. Luo Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells Cell. Mol. Biol. (Noisy-le-Grand) 48 2002 699 707
133. L.A. Snow, L. Hovanec, and J. Brandt A controlled trial of aromatherapy for agitation in nursing home patients with dementia J. Altern. Complement. Med. 10 2004 431 437
134. P.R. Solomon, F. Adams, A. Silver, J. Zimmer, and R. DeVeaux Ginkgo for memory enhancement: a randomized controlled trial JAMA 288 2002 835 840
135. J.P. Spencer, G.G. Kuhnle, R.J. Williams, and C. Rice-Evans Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites Biochem. J. 372 2003 173 181
136. R.W. Stackman, F. Eckenstein, B. Frei, D. Kulhanek, J. Nowlin, and J.F. Quinn Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment Exp. Neurol. 184 2003 510 520
137. Y. Sumanont, Y. Murakami, M. Tohda, O. Vajragupta, K. Matsumoto, and H. Watanabe Evaluation of the nitric oxide radical scavenging activity of manganese complexes of curcumin and its derivative Biol. Pharm. Bull. 27 2004 170 173
138. R.E. Tanzi, and L. Bertram New frontiers in Alzheimer's disease genetics Neuron 32 2001 181 184
139. R.E. Tanzi, and L. Bertram Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective Cell 120 2005 545 555
140. R. Tehranian, H. Hasanvan, K. Iverfeldt, C. Post, and M. Schultzberg Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576 Neurosci. Lett. 301 2001 54 58
141. B.J. Tesch Herbs commonly used by women Am. J. Obstet. Gynecol. 188 2003 S44 S55
142. J. Thome, W. Gsell, M. Rosler, J. Kornhuber, L. Frolich, B. Hashimoto, B. Zielke, G.A. Wiesbeck, and P. Riederer Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease Life Sci. 60 1997 13 19
143. L. Thorgrimsen, A. Spector, A. Wiles, and M. Orrell Aroma therapy for dementia Cochrane Database Syst. Rev. 3 2003 CD003150
144. N.T. Tildesley, D.O. Kennedy, E.K. Perry, C.G. Ballard, S. Savelev, K.A. Wesnes, and A.B. Scholey Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers Pharmacol. Biochem. Behav. 75 2003 669 674
145. C. Tohda, N. Matsumoto, K. Zou, M.R. Meselhy, and K. Komatsu Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins Neuropsychopharmacology 29 2004 860 868
146. M. van Dongen, E. van Rossum, A. Kessels, H. Sielhorst, and P. Knipschild Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial J. Clin. Epidemiol. 56 2003 367 376
147. M.H. Veerendra Kumar, and Y.K. Gupta Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats Clin. Exp. Pharmacol. Physiol. 30 2003 336 342
148. G. Veurink, D. Liu, K. Taddei, G. Perry, M.A. Smith, T.A. Robertson, E. Hone, D.M. Groth, C.S. Atwood, and R.N. Martins Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants Free Radical Biol. Med. 34 2003 1070 1077
149. D.M. Walsh, M. Townsend, M.B. Podlisny, G.M. Shankar, J.V. Fadeeva, O.E. Agnaf, D.M. Hartley, and D.J. Selkoe Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation J. Neurosci. 25 2005 2455 2462
150. H. Wang, Y. Lu, and H.Z. Chen Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice Neurosci. Lett. 344 2003 173 176
151. C.M. Watanabe, S. Wolffram, P. Ader, G. Rimbach, L. Packer, J.J. Maguire, P.G. Schultz, and K. Gohil The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba Proc. Natl. Acad. Sci. U. S. A. 98 2001 6577 6580
152. R.J. Williams, J.P. Spencer, and C. Rice-Evans Flavonoids: antioxidants or signalling molecules? Free Radical Biol. Med. 36 2004 838 849
153. E.M. Williamson Synergy and other interactions in phytomedicines Phytomedicine 8 2001 401 409
154. G. Williamson, and C. Manach Bioavailability and bioefficacy of polyphenols in humans: II. Review of 93 intervention studies Am. J. Clin. Nutr. 81 Suppl. 1 2005 243S 255S
155. D.M. Wong, H.M. Greenblatt, H. Dvir, P.R. Carlier, Y.F. Han, Y.P. Pang, I. Silman, and J.L. Sussman Acetylcholinesterase complexed with bivalent ligands related to huperzine A: experimental evidence for species-dependent protein-ligand complementarity J. Am. Chem. Soc. 125 2003 363 373
156. Z. Wu, J.V. Smith, V. Paramasivam, P. Butko, I. Khan, J.R. Cypser, and Y. Luo Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans Cell. Mol. Biol. (Noisy-le-Grand) 48 2002 725 731
157. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P. Chen, R. Kayed, C.G. Glabe, S.A. Frautschy, and G.M. Cole Curcumin inhibits formation of amyloid {beta} oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 280 2005 5892 5901
158. Z. Yao, K. Drieu, and V. Papadopoulos The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands Brain Res. 889 2001 181 190
159. K.A. Youdim, and J.A. Joseph A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects Free Radical Biol. Med. 30 2001 583 594
160. K.A. Youdim, B. Shukitt-Hale, and J.A. Joseph Flavonoids and the brain:
161. P.P. Zandi, J.C. Anthony, A.S. Khachaturian, S.V. Stone, D. Gustafson, J.T. Tschanz, M.C. Norton, K.A. Welsh-Bohmer, J.C. Breitner Cache County Study Group Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study Arch. Neurol. 61 2004 82 88
162. A. Zangara The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease Pharmacol. Biochem. Behav. 75 2003 675 686
163. J.M. Zhang, and G.Y. Hu Huperzine A, a nootropic alkaloid, inhibits N-methyl-d-aspartate-induced current in rat dissociated hippocampal neurons Neuroscience 105 2001 663 669
164. Y.H. Zhang, X.Y. Zhao, X.Q. Chen, Y. Wang, H.H. Yang, and G.Y. Hu Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex Neurosci. Lett. 319 2002 107 110
165. Z.J. Zhang, Y.H. Qian, H.T. Hu, J. Yang, and G.D. Yang The herbal medicine Dipsacus asper wall extract reduces the cognitive deficits and overexpression of beta-amyloid protein induced by aluminum exposure Life Sci. 73 2003 2443 2454
166. H.Y. Zhang, H. Yan, and X.C. Tang Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells Neurosci. Lett. 360 2004 21 24
167. L.J. Zhou, and X.Z. Zhu Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide J. Pharmacol. Exp. Ther. 293 2000 982 988
168. M. Zimmermann, B. Borroni, F. Cattabeni, A. Padovani, and M. Di Luca Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients Neurobiol. Dis. 19 2005 237 242